CD147-CAR T cells, which contain a humanized single-chain variable fragment targeting CD147, showed potent antitumor activity against the human T-ALL cell line and T-ALL blasts, releasing high levels of cytokines in the process. The gene discussed is BSG; the disease is acute lymphoblastic leukemia.